Tenosynovial giant cell tumors: Evidence for a desmin-positive dendritic cell subpopulation

Modern Pathology

Volumn 11, Issue 10, 1998, Pages 939-944

  Folpe, Andrew L ^a,e   Weiss, Sharon W ^b   Fletcher, Christopher D M ^c   Gown, Allen M ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d PHENOPATH LABORATORIES   (United States)

^e EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Desmin; Immunohistochemistry; Nuclear regulatory proteins; Rhabdomyosarcoma; Tenosynovial giant cell tumor

Indexed keywords

ALPHA ACTIN; BLOOD CLOTTING FACTOR 13A; CD45 ANTIGEN; CD68 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKERATIN; DESMIN; MYOD1 PROTEIN; MYOGENIN;

ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DIAGNOSTIC ERROR; GIANT CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOSARCOMA; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; SYNOVIUM; TENDON SHEATH;

ACTINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; DENDRITIC CELLS; DESMIN; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MYOD PROTEIN; MYOGENIN; SYNOVITIS, PIGMENTED VILLONODULAR;

EID: 0031790961     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St. Louis: Mosby; 1995. p. 735-49.
2. O'Connell JX, Fanburg JC, Rosenberg AE. Giant cell tumor of tendon sheath and pigmented villonodular synovitis: immunophenotype suggests a synovial cell origin. Hum Pathol 1995;26:771-5.
3. Fletcher CDM. Soft tissue tumors. In: Fletcher CDM, editor. Diagnostic histopathology of tumors. New York: Churchill Livingstone; 1995. p. 1043-97.
4. Merchant W, Calonje E, Fletcher CDM. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 1995;27:525-32.
5. Wang NP, Marx I, McNutt MA, Rutledge JC, Gown AM. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-810.
6. Gown AM, de Wever N, Battifora H. Microwave-based antigenie unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1:256-66.
7. Doglioni C, Dell'Orto P, Zanetti G, Iuzzolino P, Coggi G, Viale G. Cytokeratin immunoreactive cells of human lymph nodes and spleen in normal and reactive conditions. Virchows Arch A Pathol Anat Histopathol 1990;416:479-90.
8. Franke WW, Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation 1987;36: 145-63.
9. Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996;20:944-55.
10. Chan JKC, Fletcher CDM, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma: clinicopathological analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294-313.
11. Silverman J, Knapik M. Fibroma of tendon sheath is rich in Factor XIIIa+ dendrocytes [abstract]. Am J Clin Pathol 1994; 105:519.
12. Ushijima M, Hashimoto H, Tsuneyoshi M, Enjoji M. Giant cell tumor of the tendon sheath (nodular tenosynovitis): a study of 207 cases to compare the large joint group with the common digit group. Cancer 1986;57:875-84.
13. Alguacil-Garcia A, Unni KK, Goellner JR. Giant cell tumor of tendon sheath and pigmented villonodular synovitis: an ultrastructural study. Am J Clin Pathol 1978;69:6-17.
14. Tos AP, Doglioni C, Laurino L, Fletcher CD. KP1 (CD68) expression in benign neural tumours: further evidence of its low specificity as a histiocytic/myeloid marker. Histopathology 1993;23:185-7.
15. Tsang WYW, Chan JKC. KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker of lysosomes rather than the histiocytic lineage? Histopathology 1992;21:84-6.
16. Wood GS, Beckstead JH, Medeiros LJ, Kempson RL, Warnke RA. The cells of giant cell tumor of tendon sheath resemble osteoclasts. Am J Surg Pathol 1988;12:444-52.
17. Maluf HM, DeYoung BR, Swanson PE, Wick MR. Fibroma and giant cell tumor of tendon sheath: a comparative histological and immunohistological study. Mod Pathol 1995;8: 155-9.
18. Shinjo K, Miyake N, Takahashi Y. Malignant giant cell tumor of the tendon sheath: an autopsy report and review of the literature. Jpn J Clin Oncol 1993;23:317-24.
19. Ling L, Klein MJ, Sissons HA, Steiner GC. Lysozyme and α-1-antitrypsin in giant cell tumors of bone and in other lesions that contain giant cells. Arch Pathol Lab Med 1986; 110:713-8.
20. True LD. Atlas of diagnostic immunohistopathology. New York: Gower; 1990. p. 4.7-4.8.
21. Altmannsberger M, Weber K, Droste R, Osborn M. Desmin is a specific marker of rhabdomyosarcomas of human and rat origin. Am J Pathol 1985;118:85-95.
22. Tsokos M. The role of immunocytochemistry in the diagnosis of rhabdomyosarcoma. Arch Pathol Lab Med 1986;110: 776-8.
23. Truong LD, Randaeng S, Cagle P, Ro JY, Hawkins H, Font RL. The diagnostic utility of desmin. Am J Clin Pathol 1990;93: 305-14.
24. Miettinin M, Lehto VP, Bradley RA, Virtanen I. Alveolar rhabdomyosarcoma: demonstration of the muscle type of intermediate filament, desmin, as a diagnostic aid. Am J Pathol 1982;108:246-51.
25. Folpe AL, Patterson K, Gown AM. Antibodies to desmin identify the blastemal component of nephroblastoma. Mod Pathol 1997;10:895-900.
26. Parham DM, Dias P, Kelly DR, Rutledge JC, Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992;16:483-92.
27. Hurlimann J. Desmin and neural marker expression in mesothelial cells and mesothelioma. Hum Pathol 1994;25:753-7.
28. Zeng L, Fleury-Feith J, Monnet I, Boutin C, Bignon J, Jaurand MC. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies [see comments]. Hum Pathol 1994;25:227-34.
29. Rangdaeng S, Truong LD. Comparative immunohistochemical staining for desmin and muscle-specific actin: a study of 576 cases. Am J Clin Pathol 1991;96:32-45.
30. Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead JT, et al. a smooth muscle actin and desmin-positive human neuroblastoma cell lines. Int J Cancer 1991;48:277-83.
31. Wang NP, Bacchi CE, Jiang JJ, McNutt MA, Gown MA. Does alveolar soft part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. Mod Pathol 1996;9: 496-501.
32. Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms: results of an intergroup rhabdomyosarcoma study project. Cancer 1991;67:3072-80.
33. Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol 1997;21: 153-63.
34. Nielsen AL, Klaer T. Malignant giant cell tumor of the synovium and locally destructive pigmented villonodular synovitis: Ultrastructural and immunohistochemical study and review of the literature. Hum Pathol 1989;20:765-71.
35. Swanson, PE. HIERanarchy: the state of the art in immunohistochemistry. Am J Clin Pathol 1997;107:139-40.
36. Bacchi CE, Zarbo RJ, Jiang JJ, Gown AM. Do gliomas express cytokeratin? Appl Immunohistochem 1995;3:45-53.
37. Dias P, Parham DM, Shapiro DN, Tapscott SJ, Houghton PJ. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res 1992;52:6431-9.
38. Tsokos M, Dias P, Jefferson J, Houghton PJ. Detection of the MyoD1 gene product in paraffin sections of pediatric tumors [abstract]. Mod Pathol 1994;7:148A.
39. Dias P, Parham DM, Shapiro DN, Webber BL, Houghton PJ. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990;137:1283-91.
40. Wesche WA, Fletcher CDM, Dias P, Houghton PJ, Parham DM. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995;19:261-9.
41. Garrels JI, Gibson W. Identification and characterization of multiple forms of actin. Cell 1976;9:793-805.
42. Tsukada T, McNutt MA, Ross R, Gown AM. HHF-35: a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol 1987;127:389-402.
43. Schmidt RA, Cone R, Haas JE, Gown AM. Diagnosis of rhabdomyosarcoma with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol 1988;131:19-28.
44. Azumi N, Ben-Ezra J, Battifora H. Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarcoma with monoclonal antibodies to muscle-specific actin and desmin in formalin-fixed tissue. Mod Pathol 1988;1:469-74.